Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chemotherapy Induced usea and Vomiting - Overview
Chemotherapy Induced usea and Vomiting - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Chemotherapy Induced usea and Vomiting - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chemotherapy Induced usea and Vomiting - Companies Involved in Therapeutics Development
Acacia Pharma Ltd
AcuCort AB
Amzell BV
Aphios Corp
Arovella Therapeutics Ltd
Athenex Inc
Axim Biotechnologies Inc
Benuvia Therapeutics Inc
Bionorica SE
Camurus AB
Daewoong Pharmaceutical Co Ltd
Ethicann Pharmaceuticals Inc
Helsinn Group
Hoverink Biotechnologies Inc
IntelGenx Corp
Jiangsu Hengrui Medicine Co Ltd
LipoSeuticals Inc
LP Pharmaceutical (Xiamen) Co Ltd
Luxe Pharmaceuticals Inc
MannKind Corp
Senzer Ltd
Shackelford Pharma Inc
Skye Bioscience Inc
SoluBest Ltd
Starton Therapeutics Inc
Yichang Humanwell Pharmaceutical Co Ltd
Chemotherapy Induced usea and Vomiting - Drug Profiles
(fosnetupitant chloride hydrochloride + palonosetron hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
History of Events
(netupitant + palonosetron hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
History of Events
AMZ-004 - Drug Profile
Product Description
Mechanism Of Action
APD-403 - Drug Profile
Product Description
Mechanism Of Action
History of Events
aprepitant - Drug Profile
Product Description
Mechanism Of Action
aprepitant - Drug Profile
Product Description
Mechanism Of Action
aprepitant - Drug Profile
Product Description
Mechanism Of Action
dexamethasone - Drug Profile
Product Description
Mechanism Of Action
History of Events
drobinol - Drug Profile
Product Description
Mechanism Of Action
History of Events
drobinol - Drug Profile
Product Description
Mechanism Of Action
History of Events
drobinol - Drug Profile
Product Description
Mechanism Of Action
History of Events
drobinol - Drug Profile
Product Description
Mechanism Of Action
drobinol - Drug Profile
Product Description
Mechanism Of Action
drobinol - Drug Profile
Product Description
Mechanism Of Action
drobinol - Drug Profile
Product Description
Mechanism Of Action
History of Events
fosnetupitant chloride hydrochloride - Drug Profile
Product Description
Mechanism Of Action
History of Events
frovatriptan dimeglumine - Drug Profile
Product Description
Mechanism Of Action
granisetron - Drug Profile
Product Description
Mechanism Of Action
History of Events
granisetron - Drug Profile
Product Description
Mechanism Of Action
History of Events
HR-20013 - Drug Profile
Product Description
Mechanism Of Action
LPI-1504 - Drug Profile
Product Description
Mechanism Of Action
LPI-1505 - Drug Profile
Product Description
Mechanism Of Action
NB-1222 - Drug Profile
Product Description
Mechanism Of Action
History of Events
olanzapine - Drug Profile
Product Description
Mechanism Of Action
History of Events
ondansetron - Drug Profile
Product Description
Mechanism Of Action
History of Events
ondansetron hydrochloride - Drug Profile
Product Description
Mechanism Of Action
History of Events
ondansetron hydrochloride - Drug Profile
Product Description
Mechanism Of Action
History of Events
palonosetron - Drug Profile
Product Description
Mechanism Of Action
palonosetron hydrochloride LA - Drug Profile
Product Description
Mechanism Of Action
History of Events
SPID-301 - Drug Profile
Product Description
Mechanism Of Action
Zindol - Drug Profile
Product Description
Mechanism Of Action
History of Events
Chemotherapy Induced usea and Vomiting - Dormant Projects
Chemotherapy Induced usea and Vomiting - Discontinued Products
Chemotherapy Induced usea and Vomiting - Product Development Milestones
Featured News & Press Releases
Mar 01, 2022: AcuCort is exempted from the application fee by the U.S. Food and Drug Administration
Feb 22, 2022: AcuCort enters agreement with the pharmaceutical manufacturer Adhex Pharma regarding commercial and large-scale production of ISICORT
Feb 17, 2022: AcuCort announces that the company signs an agreement with consulting company in pharmacovigilance before the upcoming commercialization of ISICORT
Dec 02, 2021: Helsinn announces European Commission approval of the liquid formulation of AKYNZEO (fosnetupitant/palonosetron)
Nov 30, 2021: ESMO: Fosnetupitant is valuable in the prophylaxis of acute, delayed, and beyond delayed cinv
Oct 05, 2021: AcuCort’s drug ISICORT demonstrates a three-year shelf life
Oct 05, 2021: REDUVO- A major milestone for Tetra Bio-Pharma
Sep 03, 2021: AcuCort receives a second US patent protection for its drug ISICORT
Jun 16, 2021: Starton Therapeutics phase 2 TROPIC-I clinical study will be first to use total control primary endpoint in superiority study
Jun 02, 2021: Health Cada accepts new drug submission for REDUVO as a treatment for patients with chemotherapy-induced usea and vomiting
May 05, 2021: DanCann Pharma have signed a definitive distribution agreement with Tetra Bio-Pharma for the exclusive distribution of Reduvo Adversa and Qixleef in Scandivia and Germany
May 03, 2021: Tetra Bio-Pharma granted a drug establishment license to distribute REDUVO soft gel capsules in Cada
Apr 26, 2021: AcuCort progresses into a new phase and strengthens the commercialization team
Apr 14, 2021: Tetra Bio-Pharma provides update on its New Drug Submission application in Cada
Apr 13, 2021: Helsinn announces poster presentation at Academy of Maged Care Pharmacy (AMCP) 2021 Virtual Meeting evaluating healthcare resource utilization in CINV
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by AcuCort AB, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Amzell BV, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Arovella Therapeutics Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Axim Biotechnologies Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Benuvia Therapeutics Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Bionorica SE, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Ethicann Pharmaceuticals Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Group, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Hoverink Biotechnologies Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by IntelGenx Corp, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by LipoSeuticals Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by LP Pharmaceutical (Xiamen) Co Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Luxena Pharmaceuticals Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Senzer Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Shackelford Pharma Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Skye Bioscience Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Starton Therapeutics Inc, 2022
Chemotherapy Induced Nausea and Vomiting - Pipeline by Yichang Humanwell Pharmaceutical Co Ltd, 2022
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, 2022
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, 2022 (Contd..1)
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, 2022 (Contd..2)
Chemotherapy Induced Nausea and Vomiting - Discontinued Products, 2022